Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Luigina Romani; Vasileios Oikonomou; Silvia Moretti; Rossana G. Iannitti; Maria Cristina D’Adamo; Valeria Rachela Villella; Marilena Pariano; Luigi Sforna; Monica Borghi; Marina Maria Bellet; Francesca Fallarino; Maria Teresa Pallotta; Giuseppe Servillo; Eleonora Ferrari; Paolo Puccetti; Guido Guido Kroemer; Mauro Pessia; Luigi Maiuri; Allan L. Goldstein; Enrico Garaci

doi:10.1038/nm.4305

Corrigendum2018

Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Luigina Romani, Vasileios Oikonomou, Silvia Moretti, Rossana G. Iannitti, Maria Cristina D’Adamo, Valeria Rachela Villella, Marilena Pariano, Luigi Sforna, Monica Borghi, Marina Maria Bellet, Francesca Fallarino, Maria Teresa Pallotta, Giuseppe Servillo, Eleonora Ferrari, Paolo Puccetti, Guido Guido Kroemer, Mauro Pessia, Luigi Maiuri, Allan L. Goldstein, Enrico Garaci

Corrigendum2018

Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Luigina Romani, Vasileios Oikonomou, Silvia Moretti, Rossana G. Iannitti, Maria Cristina D’Adamo, Valeria Rachela Villella, Marilena Pariano, Luigi Sforna, Monica Borghi, Marina Maria Bellet, Francesca Fallarino, Maria Teresa Pallotta, Giuseppe Servillo, Eleonora Ferrari, Paolo Puccetti, Guido Guido Kroemer, Mauro Pessia, Luigi Maiuri, Allan L. Goldstein, Enrico Garaci

Article2017

Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Discussion(0)

Related publications

Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Strategies for the etiological therapy of cystic fibrosis

Towards a rational combination therapy of cystic fibrosis

Heart-lung transplantation for cystic fibrosis.